The controlled-release oxycodone tablet formulation (OCRT) was approved in China in 2004 for management of moderate to severe cancer pain. Few data about the efficacy of OCRT and clinical outcomes ...

The FDA notes the following OxyContin drug interactions: The American Addiction Centers and NDIC say OxyContin ...

Researchers from three universities in the Polish Baltic city of Gdańsk have developed a new crystalline form of ...

The global multiple unit pellet systems market is poised to exhibit steady growth from 2025 to 2035, expanding from USD 3,863.8 million to USD 5,294.4 million at a CAGR of 3.2%, according to recent ...

Elite's product lines consist of immediate-release and controlled-release, solid oral dose products, which are marketed under the Elite Laboratories label, as well as pursuant to licenses granted ...

This was an open-label, multicentre trial. Ten hospitals participated in this trial. It was approved by the investigators' institutional review board. The study was carried out in accordance with ...

Elite's product lines consist of immediate-release and controlled-release, solid oral dose products, which are marketed under the Elite Laboratories label, as well as pursuant to licenses granted to ...